Study details
Enrolling now
Aviclear Trial for Hidradenitis Suppurativa
University of Miami
NCT IDNCT06801795ClinicalTrials.gov data as of Apr 2026
Target enrollment
8
Study length
about 1 year
Ages
18–60
Locations
1 site in FL
About this study
Researchers are testing a device called Aviclear to treat hidradenitis suppurativa (HS). The trial will last about 382 days and involve approximately 8 participants. The goal is to evaluate the safety and effectiveness of this treatment.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use AviClear
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Change in pain as measured by Visual Analogue Scale Pain Rating Scale